What Researchers Did
Researchers reviewed the principles, physiological mechanisms, and applications of hyperbaric oxygen therapy (HBOT).
What They Found
They found that hyperbaric oxygen therapy (HBOT) involves providing 100% oxygen in a pressurized chamber, with effects being dose-dependent based on treatment depth and duration. HBOT can serve as a primary or adjunctive treatment, physiologically working to deliver oxygen-rich plasma to hypoxic tissue, prevent reperfusion injury, and enhance immune response.
What This Means for Canadian Patients
Canadian patients with conditions involving tissue hypoxia, compromised immune function, or those at risk of reperfusion injury might benefit from considering hyperbaric oxygen therapy as a treatment option. This therapy could be used alone or alongside existing medications and surgical procedures to improve healing and outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this review is that it does not present specific clinical trial data or comparative effectiveness outcomes for hyperbaric oxygen therapy.